Abstract
Diseases caused by Chlamydia trachomatis infection and its sequelae represent major public health concerns worldwide. In order to rationally develop an effective vaccine to chlamydial infection, we need a better understanding of the mechanisms underlying the protective and pathological immune responses to chlamydial antigens. Recent studies in chlamydial immunobiology have demonstrated a close link between cytokine production patterns and the type of immune responses to this pathogen. In particular, IL-10 has been found to be associated with susceptibility to chlamydial infection and the typical pathological changes caused by the infection such as granuloma formation and fibrosis. Although Th1 type delayed hypersensitivity (DTH) is associated with protective immunity, the Th2 type DTH documented in interferon (IFN)-γ gene knockout (KO) mice fails to control chlamydial infection. The Th2 type DTH is characterized by eosinophil and neutrophil infiltration and is associated with high levels of IL-4 and IL-5 production. The capability of dendritic cell (DC) in initiating T cell response to Chlamydia has been shown in studies using cultured DCs and a DC line. Further studies should be performed to elucidate the role played by DCs in natural chlamydial infection and the potential involvement of DC subsets in directing immune responses to chlamydial infection.
Keywords: Cytokines, Chlamydia trachomatis, Immunopathology, Protective Immunity, dendritic cell, granuloma formation
Current Pharmaceutical Design
Title: Role of Cytokines in Chlamydia trachomatis Protective Immunity and Immunopathology
Volume: 9 Issue: 1
Author(s): Xi Yang
Affiliation:
Keywords: Cytokines, Chlamydia trachomatis, Immunopathology, Protective Immunity, dendritic cell, granuloma formation
Abstract: Diseases caused by Chlamydia trachomatis infection and its sequelae represent major public health concerns worldwide. In order to rationally develop an effective vaccine to chlamydial infection, we need a better understanding of the mechanisms underlying the protective and pathological immune responses to chlamydial antigens. Recent studies in chlamydial immunobiology have demonstrated a close link between cytokine production patterns and the type of immune responses to this pathogen. In particular, IL-10 has been found to be associated with susceptibility to chlamydial infection and the typical pathological changes caused by the infection such as granuloma formation and fibrosis. Although Th1 type delayed hypersensitivity (DTH) is associated with protective immunity, the Th2 type DTH documented in interferon (IFN)-γ gene knockout (KO) mice fails to control chlamydial infection. The Th2 type DTH is characterized by eosinophil and neutrophil infiltration and is associated with high levels of IL-4 and IL-5 production. The capability of dendritic cell (DC) in initiating T cell response to Chlamydia has been shown in studies using cultured DCs and a DC line. Further studies should be performed to elucidate the role played by DCs in natural chlamydial infection and the potential involvement of DC subsets in directing immune responses to chlamydial infection.
Export Options
About this article
Cite this article as:
Yang Xi, Role of Cytokines in Chlamydia trachomatis Protective Immunity and Immunopathology, Current Pharmaceutical Design 2003; 9 (1) . https://dx.doi.org/10.2174/1381612033392486
DOI https://dx.doi.org/10.2174/1381612033392486 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Multidisciplinary Pharmaceutical Drug Design Strategies in the Progress of Drug Discovery"
The process of developing a drug is time and money-consuming, but also fascinating. The development of numerous computational techniques, synthetic methodologies, formulation-based drug discovery, etc., has improved the drug discovery process. The process of developing new drugs is significantly hampered by drug-poor pharmacodynamics and pharmacokinetic problems. To address these challenges, ...read more
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-Based Biomarkers in Large-Scale Screening for Neurodegenerative Diseases
Disease biomarkers are necessary tools that can be employed in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, and prediction, to monitoring of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal ...read more
Diabetes Mellitus: Advances in Diagnosis and Treatment driving by Precision Medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
<i>In Silico</i> Studies for Bacterystic Evaluation against <i>Staphylococcus aureus</i> of 2-Naphthoic Acid Analogues
Current Topics in Medicinal Chemistry New Chalcones Containing Nucleosides Exhibiting In Vitro Anti-cancer Activities
Letters in Organic Chemistry Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer’s Disease
Current Pharmaceutical Design The Role of Essential Oils and the Biological Detoxification in the Prevention of Aflatoxin Borne Diseases
Current Topics in Medicinal Chemistry Unveiling the Anti-tubercular Properties of Biscoumarins, through Biological Evaluation and Docking Studies
Letters in Drug Design & Discovery A Collaborative Edge-Cloud Internet of Things Based Framework for Securing the Indian Healthcare System
International Journal of Sensors, Wireless Communications and Control Pulmonary Drug Delivery System: A Novel Approach for Drug Delivery
Current Drug Therapy Influence of Leptin on Immunity
Current Immunology Reviews (Discontinued) Advancements within Modern Machine Learning Methodology: Impacts and Prospects in Biomarker Discovery
Current Medicinal Chemistry α-Galactosylceramide: Potential Immunomodulatory Activity and Future Application [General Articles]
Current Medicinal Chemistry Vaccine Adjuvants: Key Tools for Innovative Vaccine Design
Current Topics in Medicinal Chemistry Recent Developments in Particulate-Based Vaccines
Recent Patents on Drug Delivery & Formulation Nrf2/HO-1 Mediated Antioxidant Activities, Cytotoxicity Analysis and LCESI/ MS Profiling of Eulophia nuda L.
The Natural Products Journal Novel Antibacterial Agents: An Emergent Need to Win the Battle Against Infections
Mini-Reviews in Medicinal Chemistry Metabolomics in the Diagnosis and Pharmacotherapy of Lung Diseases
Current Pharmaceutical Design Is There a Role for Antioxidants in the Prevention of Infection-Associated Carcinogenesis and in the Treatment of Infection-Driven Tumors?
Current Topics in Medicinal Chemistry The Application of Xpert Mycobacterium tuberculosis/Rifampicin, Quantitative Polymerase Chain Reaction and High Resolution Melting Curve in the Diagnosis of Superficial Lymph Node TB.
Current Pharmaceutical Biotechnology Current Status of Target-Based Antimycobacterial Natural Products
Anti-Infective Agents in Medicinal Chemistry Pathophysiology, Current Therapeutic Options, Vaccine Candidates, and Drug Targets for Human Brucellosis
Current Molecular Pharmacology Lipid-based Vesicular Nanocargoes as Nanotherapeutic Targets for the Effective Management of Rheumatoid Arthritis
Recent Patents on Anti-Infective Drug Discovery